Dysport in Vulvodynia Phase II Study
Public ClinicalTrials.gov record NCT03598777. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicentre, Double-blind, Randomised, Placebo Controlled, Dose Escalation and Dose Finding Study to Evaluate the Efficacy and Safety of Dysport in Vulvodynia Patients
Study identification
- NCT ID
- NCT03598777
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ipsen
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Botulinum toxin type A Biological
- Placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2018
- Primary completion
- Jan 20, 2021
- Completion
- Jan 20, 2021
- Last update posted
- Dec 8, 2021
2018 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| James A. Simon, MD, PC | Washington D.C. | District of Columbia | 20036 | — |
| The Center for Vulvovaginal Disorders | Washington D.C. | District of Columbia | 20037 | — |
| New Age Medical Research Corporation | Miami | Florida | 33186 | — |
| University of Kansas Medical Center | Kansas City | Missouri | 66160 | — |
| Omaha OB-GYN Associates, PC | Omaha | Nebraska | 68130 | — |
| The Center for Vulvovaginal Disorders | New York | New York | 10036 | — |
| Women's Institute for Sexual Health (WISH) | Nashville | Tennessee | 37209 | — |
| Seattle Women's: Health, Research, Gynecology® | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03598777, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03598777 live on ClinicalTrials.gov.